Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-08-30FDA Approved: ALLOPURINOL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Allopurinol from Camber Pharmaceuticals, Inc. under the ANDA program. This action constitutes a …
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED) [Phase 4]
This completed Phase 4 trial compared etoricoxib to indomethacin for treating acute gout. The study assessed the efficacy and safety of the …
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout
A clinical trial update examining the role of the NLRP3 inflammasome in intercritical gout, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-08-05Clinical Trial Update: A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment. [Phase 2]
A Phase 2 clinical study evaluating SSGJ-613 in gout patients initiating urate-lowering therapy.
-
FDA approval · 2024-07-22FDA Approved: FEBUXOSTAT — Supplemental Application (HEC Pharm USA Inc.)
FDA approved a supplemental application for FEBUXOSTAT submitted by HEC Pharm USA Inc. The action supplements the approved Febuxostat produc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Acute Effects of Tart Cherry on Uric Acid and Biomarkers of CVD Risk in Healthy Individuals [NA]
A completed clinical trial evaluating the acute effects of tart cherry on uric acid levels and biomarkers of cardiovascular disease risk in …
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: The Effect of Tart Cherry Juice on Risk of Gout Attacks [NA]
A clinical trial evaluating the effect of tart cherry juice on the risk of gout attacks was terminated.
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare [Phase 4]
Phase 4 trial evaluating the relationship between colchicine blood concentration and response in gout flare; the study was terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Nurse Led Patient Management Programme to Improve Outcomes in Gout [NA]
Completed clinical trial evaluating a nurse-led patient management program to improve outcomes in gout and related arthritis.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Gout Self-Monitoring Aiming to Reach Target [NA]
A completed clinical trial on self-monitoring for gout has posted results as of 2024-05-21. The study was conducted at the University of Edi…
-
FDA approval · 2024-05-16FDA Approved: MITIGARE — Supplemental Application (Hikma Specialty USA Inc.)
FDA approved a supplemental application for Mitigare (colchicine) submitted by Hikma Specialty USA Inc. The action updates the product label…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults [Phase 3]
This document reports a Phase 3 clinical trial of HR091506 tablets for gout with hyperuricemia in adults that is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
Clinical trial update examining immune cell distribution and subtypes in peripheral blood of individuals with gout, including gout flare, in…
-
FDA approval · 2024-04-29FDA Approved: COLCHICINE — Original Application (Granules Pharmaceutical Inc.)
FDA approved an Original Application for a generic colchicine product by Granules Pharmaceutical Inc., establishing a generic option for col…
-
FDA approval · 2024-04-29FDA Approved: COLCHICINE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals’ generic colchicine under an original ANDA, authorizing its marketing as a generic product.
-
FDA approval · 2024-04-29FDA Approved: COLCHICINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for a generic colchicine product.
-
FDA approval · 2024-04-03FDA Approved: ALLOPURINOL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Allopurinol from Actavis Pharma, Inc., authorizing changes to the product’s labeling.
-
FDA label_change · 2024-03-08FDA Approved: ALLOPURINOL — Supplemental Application (Harman Finochem Limited)
FDA approved a supplemental application for Allopurinol, approving changes to the labeling for Harman Finochem Limited's generic Allopurinol…
-
FDA approval · 2024-02-16FDA Approved: ALLOPURINOL — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for Allopurinol submitted by Par Health USA, LLC.
-
FDA approval · 2024-02-05FDA Approved: ALLOPURINOL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for allopurinol from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals) under ANDA204467. The app…
-
FDA approval · 2024-02-05FDA Approved: ALLOPURINOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for ALLOPURINOL (Allopurinol) submitted by Zydus Lifesciences Limited, authorizing changes to the ap…
-
FDA approval · 2024-01-29FDA Approved: ALLOPURINOL — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Allopurinol from Sun Pharmaceutical Industries, Inc., indicating an approved update to the drug'…
-
FDA label_change · 2024-01-29FDA Approved: ALLOPURINOL — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Allopurinol submitted by Unichem Pharmaceuticals (USA), Inc., resulting in changes to the produc…
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout [Phase 3]
Phase 3 clinical trial update of a recombinant anti-IL-1β monoclonal antibody for acute gout in Chinese participants.
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia [Phase 4]
Phase 4 trial reporting that orlistat reduces uric acid in overweight/obese patients with hyperuricemia.